U.S. market Closed. Opens in 29 minutes

DGX | Quest Diagnostics Incorporated Stock Overview

(Stock Exchange: NYSE)
Day's Range 154.01 - 156.24
52 Week Range 123.04 - 160.95
Beta 0.88
Implied Volatility 21.48%
IV Rank 35.88%
Day's Volume 449,448
Average Volume 743,387
Shares Outstanding 111,615,000
Market Cap 17,225,542,950
Sector Healthcare
Industry Medical - Diagnostics & Research
IPO Date 1996-12-17
Valuation
Profitability
Growth
Health
P/E Ratio 20.74
Forward P/E Ratio 14.71
EPS 7.44
1YR Price Target 154.00
Dividend Yield 1.93%
Dividend Per Share 2.12
Dividend ExDate 2023-01-17
Dividend PayDate 2023-02-01
Employees 50,000
Country USA
Website DGX
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
DGX's peers: IQV, MTD, TWST, WAT, ICLR, IDXX, CRL, RVTY, SHC, A, LH
*Chart delayed
Analyzing fundamentals for DGX we got that it has strong fundamentals where Valuation is considered to be significantly undervalued, Profitability is wealthy, Growth is very good and Health is passable. For more detailed analysis please see DGX Fundamentals page.

Watching at DGX technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on DGX Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙